Januvia is a dipeptidyl peptidase-4 (DPP-4) inhibitor for use in patients with type 2 diabetes. It first hit the market in October 2006. Only three years later, investigators linked Januvia to the development of pancreatic cancer in patients. Since then, numerous studies have shown a connection between the drug and inflammation of the pancreas as well as pancreatic cancer.
If Januvia has negatively affected you or a loved one, contact us. Our lawyers are investigating cases involving Januvia and may be able to help you fight for compensation from the drug manufacturer, Merck & Co. You could be eligible to recover your medical expenses, lost wages, and pain and suffering. Call today for your free legal consultation in Kansas City.
Why Choose Us?
The Dickerson Oxton Law Firm has taken many cases involving defective and dangerous consumer drugs. We have a long history of helping clients who have suffered serious injuries, illnesses, and the deaths of loved ones because of the negligence of drug manufacturers.
- We offer contingency fee-based services (if we do not win, you do not pay).
- We are dedicated to client success.
- We have years of experience handling product liability cases.
Our Kansas City, Missouri, lawyers have the trial experience, commitment to justice, and access to legal resources you need to carry your case where it needs to go. If you are suffering serious pancreatic problems after taking Januvia, contact us to request a free case review. You could be eligible for compensation.
What Is Januvia? What Are the Issues?
Januvia is a diabetic drug meant to increase the production of insulin in the pancreas, as well as reduce the body’s insulin resistance in people with type 2 diabetes. Combined with diet and exercise, Januvia can decrease and regulate blood sugar. Unfortunately, this drug is not as safe for patients as the drug maker made it out to be. The Food and Drug Administration (FDA) has issued multiple warnings to doctors and patients about the potential serious side effects of taking Januvia.
Pancreatic damage and complications are the most common injuries relating to Januvia in patients with type 2 diabetes. Several studies have concluded that Januvia – and a similar drug, Janumet – may increase the risk of pancreatic cancer and inflammation. Hundreds of patients have come forward with complaints of pancreatic problems after taking Januvia since the drug’s debut. A small number of patients exhibited an early sign of pancreatic cancer (pancreatic duct metaplasia) after taking Januvia.
Pancreatic cancer is one of the deadliest forms of cancer, with 96% of diagnosed patients passing away within five years after diagnosis. Patients who developed pancreatic problems or diseases after taking Januvia have filed lawsuits against Merck & Co. in pursuit of financial compensation for their damages. These lawsuits claim the manufacturer distributed a defective product, failed to warn consumers and physicians of known side effects, and breached warranties by selling the product. The company has faced both personal injury and wrongful death lawsuits.
Potential Compensation Options
If you or a family member suffered pancreatic damage after taking Januvia, you could be eligible for financial compensation. A product liability lawsuit could result in payment for your related medical expenses, pain and suffering, lost wages, and other damages. You could also receive payment for your court costs and attorney’s fees. A consultation with an attorney can help you discover if your situation has merit as an individual lawsuit or class action in Kansas City.
Contact Us Today
The Dickerson Oxton Law Firm can help victims of defective drugs such as Januvia. We have extensive experience handling these types of claims and are always looking for new clients with potential lawsuits. If you believe you have a case against Merck & Co. for injuries you or a loved one suffered after taking Januvia, contact us. We can discuss your rights and options during a free consultation in Kansas City. Request your meeting today at (816) 268-1960.